Business Context and Reporting Period
This Form 8-K is a current report filed by Fluidigm Corporation (noted as Standard BioTools Inc. in metadata) on August 7, 2012. The filing serves to announce the company's financial results for the second quarter of 2012 via a press release furnished as Exhibit 99.1.
Key Financial Metrics
The provided text is a cover sheet for the 8-K filing and does not contain specific financial data. It references a press release (Exhibit 99.1) for details on revenue, profit, cash flow, margins, debt, and liquidity. Consequently, no specific financial metrics are available in this text.
Material Changes
The filing text does not provide specific figures or descriptions of material changes compared to the prior comparable period. It only confirms that results for the second quarter of 2012 were reported.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, risk factors, or details on contingencies. These items are contained within the referenced press release (Exhibit 99.1), which is not included in the input text.
Investor Verification Checklist
- Verify the specific revenue and net loss figures for Q2 2012 in the attached press release (Exhibit 99.1).
- Confirm the company's cash position and burn rate as of June 30, 2012.
- Review any updated full-year 2012 guidance provided in the press release.
- Check for any material changes in operating expenses or R&D spending compared to Q2 2011.